CALGENT BIOTECHNOLOGY CO. Company
Low toxicity oral anti-cancer drug-MPT0L056, an ITCH E3 ubiquitin ligase inhibitorfor treating multiple myeloma and pancreatic cancer
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Taipei, T'ai-pei, Taiwan
Founded Date:
2019
Employees Number:
1-10
Register and Claim Ownership